Trademark: 90033523
Word
REBLOZYL
Status
Registered
Status Code
700
Status Date
Tuesday, January 26, 2021
Serial Number
90033523
Registration Number
6257051
Registration Date
Tuesday, January 26, 2021
Mark Type
3000
Filing Date
Thursday, July 2, 2020
Published for Opposition
Tuesday, November 10, 2020
Trademark Owner History
Celgene Corporation - Original Registrant
Classifications
5 Pharmaceutical preparations for use in the treatment of anemia, beta thalassemia, blood disease, cancer
The mark consists of "REBLOZYL" with three dots to the right of the word.
Trademark Events
Jan 26, 2021
Registered-Principal Register
Nov 10, 2020
Official Gazette Publication Confirmation E-Mailed
Nov 10, 2020
Published For Opposition
Oct 21, 2020
Notification Of Notice Of Publication E-Mailed
Oct 8, 2020
Approved For Pub - Principal Register
Oct 8, 2020
Assigned To Examiner
Aug 24, 2020
Preliminary/Voluntary Amendment - Entered
Aug 20, 2020
Assigned To Lie
Aug 3, 2020
Teas Voluntary Amendment Received
Jul 31, 2020
Notice Of Design Search Code E-Mailed
Jul 30, 2020
New Application Office Supplied Data Entered In Tram
Jul 6, 2020
New Application Entered In Tram
ALPINE VALLEY
S SOULAR PRODUCTIONS
Trademark Alertz updated from USPTO on 2030-01-24

Trademark Alertz ™ - GRJR PTY LTD 2024 - Privacy Policy - Terms of Use

The information provided on Trademark Alertz is not legal or professional advice. Information may have been obtained from third parties and may contain errors. You must make your own enquiries and seek independent advice from relevant industry professionals before acting or relying on any information from Trademark Alertz. All trade mark information has been obtained from and made publicly available by The United States Patent and Trademark Office (USPTO). Copyright of the trademark data resides with USPTO. www.uspto.gov